Letters to the Editor

Microbial burden of repackaged versus original-tube clobetasol propionate 0.05% after 7 days of in-use exposure: a pilot study with paired unopened controls

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 23 September 2026
76
Views
76
Downloads

Authors

Dear Editor,

In Taiwan, dermatology and primary care clinics commonly dispense clobetasol propionate 0.05% cream either in the manufacturer’s original aluminum tube or, more often, by transferring cream from larger factory containers into small plastic boxes at the clinic counter. This long-standing practice reduces drug waste and dispensing costs, but it is performed in a routine consultation environment rather than under laboratory conditions, and the destination boxes are not pre-sterilized. Patients therefore periodically express concern that repackaged creams may be more easily contaminated than original tubes. Empirical data are scarce. We undertook a small comparative pilot study with paired unopened controls (one for each packaging type) to address this concern. [...]

Downloads

Download data is not yet available.

Citations

1. Alshehrei FM. Microbiological quality assessment of skin and body care cosmetics by using challenge test. Saudi J Biol Sci 2024;31:103965.
2. Bashir A, Lambert P. Microbiological study of used cosmetic products: highlighting possible impact on consumer health. J Appl Microbiol 2020;128:598-605.
3. Iskandar K, Marchin L, Kodjikian L, et al. Highlighting the microbial contamination of the dropper tip and cap of in-use eye drops, the associated contributory factors, and the risk of infection: a past-30-years literature review. Pharmaceutics 2022;14:2176.
4. Kircik L, Siegel DM. Clinical and legal considerations in pharmaceutical compounding. J Clin Aesthet Dermatol 2023;16:S23-8.
5. Garg R, Singh H. Safety of compounded medications. Cureus 2025;17:e78541.

How to Cite



1.
Microbial burden of repackaged versus original-tube clobetasol propionate 0.05% after 7 days of in-use exposure: a pilot study with paired unopened controls. Dermatol Reports [Internet]. 2026 Sep. 23 [cited 2026 Oct. 20];. Available from: https://journals.pagepress.net/dr/article/view/10926